Room | Conference Schedule | ECHE 2010

Session	Pricing based on risk-sharing, what is it and is it relevant for the US and Europe?	Congress Hall A Thursday 10:15-11:30
Presentations	Pricing based on risk-sharing, what is it and is it relevant for the US and Europe? Pricing based on risk-sharing, what is it and is it relevant for the US and Europe?: Comment Pricing based on risk-sharing, what is it and is it relevant for the US and Europe?: Comment	Congress Hall A Thursday 10:15-11:30
Session	Cross-country comparison of costs and efficiency in the Nordic countries	Congress Hall A Thursday 11:45-13:00
Presentations	Cost of cancer: a cost of illness comparison between the Nordic countries Casemix comparison in Finnish and Swedish hospitals using different output specifications A comparative analysis of specialized health services in the Nordic countries	Congress Hall A Thursday 11:45-13:00
Session	Equity, social values and willingness to pay for QALYs in Europe	Congress Hall A Thursday 14:30-15:45
Presentations	Views of members of the public across Europe on the appropriate principles underlying the prioritisation of health care How are views about the prioritisation of health care distributed across Europe? How do views on the appropriate principles underlying the prioritisation of health care relate to individual characteristics and willingness to pay for health benefits?	Congress Hall A Thursday 14:30-15:45
Session	Estimating the costs and benefits of public health interventions	Congress Hall A Thursday 16:00-17:15
Presentations	Modelling and forecasting Dutch life expectancy and disability-free life expectancy at old age Quality of Life Lost Due to Non-Fatal Road Crashes Unrelated health care costs: excluded, included, or a bit of both? How to (best) measure outcomes in evaluations of public health interventions	Congress Hall A Thursday 16:00-17:15
Session	The effects of reference pricing in pharmaceutical markets	Congress Hall A Friday 08:30-09:45
Presentations	Reference pricing as a price coordination device: An experimental test The impact of reference pricing for drugs in Italy Demand elasticities and effectiveness of pharmaceutical policies Effects of Reference Pricing in Pharmaceutical Markets: a Review	Congress Hall A Friday 08:30-09:45
Session	Improving Health Expenditure Data as an Objective and a Policy Tool	Congress Hall A Friday 10:15-11:30
Presentations	Tracking external resources for health care in the countries from the former Soviet Union: methods and definitions Comparative analysis of health expenditure patterns in the Eastern Europe and Central Asia Assessing the impact of the Tajik Guaranteed Basic Package Scheme on patients’ expenditure in PHC and hospital settings Impact of NHA Findings on Health Policies in Georgia Reporting out-of-pocket payments for health care in countries from the former Soviet Union: Methods and definitions	Congress Hall A Friday 10:15-11:30
Session	DRG systems in Europe: How similar, how divergent? First empirical results	Congress Hall A Friday 10:15-11:30
Presentations	From HealthBASKET to EuroDRG: Background and objectives of the EuroDRG project Patient Classification: A comparison between 10 European countries DRGs and hospital efficiency: Panacea or pitfall? DRGs and quality: to the better or worse?	Congress Hall A Friday 10:15-11:30
Session	Valuing Health	Congress Hall A Friday 14:30-15:45
Presentations	The 15D instrument and its properties Expectations of and experiences from introducing the electronic version of the 15D for routine use in the Hospital District of South Karelia Bayesian methods for predicting treatment results The use of the 15D in the follow-up of cost-effectiveness of routine secondary care in the Helsinki University Hospital	Congress Hall A Friday 14:30-15:45
Session	Experiments in Health Economics	Congress Hall A Friday 16:00-17:15
Presentations	Experimental evidence on health habits and time and risk preferences Altruism and treatment decisions Using lab experiments to investigate incentive compatibility and hypothetical bias in discrete choice experiments	Congress Hall A Friday 16:00-17:15
Session	Public Hospital Waiting Times in Australia: An exploration of the determinants of waiting time, preferential treatment and the impact on demand for private health insurance	Congress Hall A Saturday 08:30-09:45
Presentations	Access block and overcrowding in Emergency Departments: a correlated hazard approach Expected waiting times and the decision to buy private health insurance Non-clinical determinants of waiting times for elective admissions in NSW public hospitals The demand for private health insurance: do waiting lists or waiting times matter?	Congress Hall A Saturday 08:30-09:45
Session	Measuring health and social care output and productivity: a European perspective	Congress Hall A Saturday 10:15-11:30
Presentations	Getting out what we put in: how productive is the NHS in England? Measuring and monitoring outcomes and outputs of social care: care homes for older adults and people with learning disability On measuring health care volume and productivity: A methodological framework with applications to Dutch health care Technological progress as a means to improve hospital productivity - easy to observe but difficult to measure	Congress Hall A Saturday 10:15-11:30

Sessions in this Room

Rooms

Search with Google